Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scientists seek to mutate H7N9, as 1st human transmission evidence emerges

This article was originally published in Scrip

Executive Summary

Just as Chinese researchers were reporting the strongest evidence yet of person-to-person transmission of the novel avian H7N9 flu, other investigators – including the same who triggered the recent firestorm over experiments with the genetically modified highly pathogenic avian influenza (HPAI) H5N1 strain – revealed their intentions to conduct gain-of-function (GOF) work on the deadly new virus.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC022380

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel